pubmed-article:16280369 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0450127 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0022663 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0033687 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0277785 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C2757068 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0439836 | lld:lifeskim |
pubmed-article:16280369 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
pubmed-article:16280369 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16280369 | pubmed:dateCreated | 2006-1-19 | lld:pubmed |
pubmed-article:16280369 | pubmed:abstractText | The study was conducted in order to describe possible intraglomerular haemodynamic changes inducing proteinuria after 14 patients with chronic allograft dysfunction were converted from calcineurin inhibitors (CIs) to sirolimus without changing concomitant immunosuppression or antihypertensive treatment. | lld:pubmed |
pubmed-article:16280369 | pubmed:language | eng | lld:pubmed |
pubmed-article:16280369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16280369 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16280369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16280369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16280369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16280369 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16280369 | pubmed:month | Feb | lld:pubmed |
pubmed-article:16280369 | pubmed:issn | 0931-0509 | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:SaurinaAnnaA | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:OppenheimerFe... | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:CampistolJose... | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:CamposBegoñaB | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:PieraCarlosC | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:de las... | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:DiekmannFritz... | lld:pubmed |
pubmed-article:16280369 | pubmed:author | pubmed-author:CamposNievesN | lld:pubmed |
pubmed-article:16280369 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16280369 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:16280369 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16280369 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16280369 | pubmed:pagination | 488-93 | lld:pubmed |
pubmed-article:16280369 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:meshHeading | pubmed-meshheading:16280369... | lld:pubmed |
pubmed-article:16280369 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16280369 | pubmed:articleTitle | Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria. | lld:pubmed |
pubmed-article:16280369 | pubmed:affiliation | Nephrology Department, Hospital de Terrassa, Spain. | lld:pubmed |
pubmed-article:16280369 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16280369 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16280369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16280369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16280369 | lld:pubmed |